Biopsy of pancreatic tumors prior to resection: for and against
https://doi.org/10.51523/2708-6011.2021-18-1-9
Abstract
The article presents modern approaches to the diagnosis of pancreatic cancer, discusses the feasibility of resectable tumor biopsy, and provides clinical cases illustrating the negative aspects associated with biopsy.
About the Authors
I. V. Mikhailov
Gomel State Medical University
Belarus
Belarus
Igor V. Mikhailov, Cand. Sc. (Medicine), Head of the Department of Oncology, Gomel
V. N. Beliakouski
Gomel State Medical University
Belarus
Belarus
Vasili N. Beliakouski, D.Sc. (Medicine), Professor, Professor at the Department of Oncology, Gomel
V. A. Kudrashou
Gomel Regional Clinical Oncology Center
Belarus
Belarus
Vadzim A. Kudrashou, Head of the Abdominal Oncology Ward, Gomel
A. P. Dyatlov
Gomel State Medical University
Belarus
Belarus
Alexandr P. Dyatlov, Assistant Lecturer at the Department of Oncology, Gomel
Ch. A.A.D. Weerakoon
Gomel State Medical University
Belarus
Belarus
Chinthana A.A.D. Weerakoon, Assistant Lecturer at the Department of OncologyGomel
References
1. Algoritmy diagnostiki i lecheniya zlokachestvennykh novoobrazovaniy : klinicheskiy protocol. Ministerstvo zdravookhraneniya Respubliki Belarus'. Minsk: Professional'nye izdaniya; 2019. 616 p. (In Russ.). https://oncopatient.by/wp-content/uploads/2019/06/W21833500p_1539378000.pdf
2. De La Cruz MS, Young AP, Ruffin MT. Diagnosis and management of pancreatic cancer. American Family Physician. 2014;89(8):626-632.
3. Hartwig W, Werner J, Jäger D, Debus J, Büchler MW. Improvement of surgical results for pancreatic cancer. Lancet Oncol. 2013 Oct;14(11):e476-e485.
4. Garcea G, Metcalfe MS, Berry DP, Robertson GS, Lloyd DM, Dennison AR. Is intraoperative confirmation of malignancy during pancreaticoduodenectomy mandatory? J Gastrointest Surg. 2012 Feb;16(2):370-5. https://doi.org/10.1007/s11605-011-1728-y
5. Hewitt MJ, McPhail MJ, Possamai L, et al. EUSguided FNA for diagnosis of solid pancreatic neoplasms: A meta-analysis. Gastrointest Endosc. 2012;75:319-31. https://doi.org/10.1016/j.gie.2011.08.049
6. Tempero MA, Malafa MP, Al-Hawary M et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. https://doi.org/10.6004/jnccn.2017.0131
7. Stepanov SO, Sidorov DV, Skreptsova NS, Prozorova EV. Ul'trazvukovaya diagnostika opukholey podzheludochnoy zhelezy. Onkologiya. Zhurnal im. P.A. Gertsena. 2014;3(2):59-67. (In Russ) https://www.mediasphera.ru/issues/onkologiya-zhurnal-im-p-agertsena/2014/2/322305-218X20150213
8. Galvin, A., Sutherland, T. & Little, A.F. Part 1: CT characterisation of pancreatic neoplasms: a pictorial essay. Insights Imaging. 2011(2):379–388. https://doi.org/10.1007/s13244-011-0102-7
9. Kostina YuD, Pavelets KV. Diagnostika i lechenie raka podzheludochnoy zhelezy. Sovremennoe sostoyanie problemy. Meditsina: teoriya i praktika. 2018;3(3):16-26. (In Russ.). https://cyberleninka.ru/article/n/diagnostikai-lechenie-raka-podzheludochnoy-zhelezy-sovremennoesostoyanie-problemy
10. Dolejs S, Zarzaur BL, Zyromski NJ. et al. Does hyperbilirubinemia contribute to adverse patient outcomes following pancreatoduodenectomy? J Gastrointest Surg. 2017;21:647–656. http://dx.doi.org/10.1007/s11605-017-3381-6
11. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014; 371: 1039–1049. https://doi.org/10.1056 / NEJMra1404198.
12. Daly M, Pilarski R, Berry M. et al. NCCN Clinical practice guidelines in oncology. Genetic/ familial highrisk assessment. V. 2.2017. J Natl Compr Canc Netw. 2017;15(1):9–20. https://doi.org/10.6004/jnccn.2017.0003
13. Takai E, Yachida S. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer. World J Gastroenterol. 2016 Oct 14;22(38):8480-8488. https://doi.org/10.3748/wjg.v22.i38.8480
14. Asbun H, Conlon K, Fernandez-Cruz L, Friess H et.al. When to Perform a Pancreatoduodenectomy in the Absence of Positive Histology? A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014 Май;155(5):887-92. https://doi.org/10.1016/j. surg. 2013. 12. 032
15. Ducreux M, Cuhna AS, Caramella C. et al. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. [Electronic resource]. September 2015. Mode of access: https://www.annalsofoncology.org/article/S0923-7534(19)47178-0/fulltext#secst0025. Date of access: 19.10.2020.
16. Nesterenko YuA, Laptev VV, Mikhaylusov SV. Diagnostika i lechenie destruktivnogo pankreatita. Moskva, 2004. 304 p. (In Russ)
17. Mikhaylov IV, Bondarenko VM, Kudryashov VA, Achinovich SL, Kiselev PG, Grabareva GL, Podgornyy NN, Shimanovskiy GM, Novak SV, Dovidovich SV, Atamanenko AV, Dyatlov AP. Dinamika rezul'tatov lecheniya rezektabel'nogo raka golovki podzheludochnoy zhelezy za 30-letniy period. Health and Ecology Issues. 2019;(3):50-55. (In Russ)
18. Gubergrits NB, Lukashevich GM, Fomenko PG, Belyaeva NV. «Rokovaya tsepochka»: ot ostrogo pankreatita k raku podzheludochnoy zhelezy. Gastroenterologiya Sankt-Peterburga. 2017;(2):15–27. (In Russ)
19. Shchastnyy AT. Posleoperatsionnye oslozhneniya proksimal'nykh rezektsiy podzheludochnoy zhelezy u patsientov s khronicheskim pankreatitom. Novosti khirurgii, 2011;19(3):30-43. (In Russ)
20. Mikhaylov IV, Bondarenko VM, Kudryashov VA, Achinovich SL, Kiselev PG, Nesterovich TN, Virakoon ChA. Odnoetapnye operatsii pri rake golovki podzheludochnoy zhelezy, oslozhnennom mekhanicheskoy zheltukhoy. Health and Ecology Issues. 2019;(3):33-37. (In Russ)
Review
For citations:
Mikhailov I.V., Beliakouski V.N., Kudrashou V.A., Dyatlov A.P., Weerakoon Ch.A. Biopsy of pancreatic tumors prior to resection: for and against. Health and Ecology Issues. 2021;18(1):62-69. (In Russ.) https://doi.org/10.51523/2708-6011.2021-18-1-9
Views: 462
Email this article 